• 1
    Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1996; 335:15701580.
  • 2
    Van de Water J, Ishibashi H, Coppel RL, Gershwin ME. Molecular mimicry and primary biliary cirrhosis: premises not promises. Hepatology 2001; 33:771775.
  • 3
    Fussey SP, Ali ST, Guest JR, James OF, Bassendine MF, Yeaman SJ. Reactivity of primary biliary cirrhosis sera with Escherichia coli dihydrolipoamide acetyltransferase (E2p): characterization of the main immunogenic region. Proc Natl Acad Sci U S A 1990; 87:39873991.
  • 4
    Fussey SP, Lindsay JG, Fuller C, Perham RN, Dale S, James OF, Bassendine MF, et al. Autoantibodies in primary biliary cirrhosis: analysis of reactivity against eukaryotic and prokaryotic 2-oxo acid dehydrogenase complexes. Hepatology 1991; 13:467474.
  • 5
    Bogdanos DP, Choudhuri K, Vergani D. Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences. Liver 2001; 21:225232.
  • 6
    Mayo I, Arizti P, Pares A, Oliva J, Doforno RA, de Sagarra MR, Rodes J, et al. Antibodies against the COOH-terminal region of E. coli ClpP protease in patients with primary biliary cirrhosis. J Hepatol 2000; 33:528536.
  • 7
    Bogdanos DP, Grasso A, Okamoto M, Montalto P, Butler P, Williams R, Baum H, et al. Cross-reactivity to Lactobacillus Delbrueckii/human pyruvate dehydrogenase complex -E2 characterizes primary biliary cirrhosis. Hepatology 2000; 32:300A.
  • 8
    Long SA, Quan C, Van de Water J, Nantz MH, Kurth MJ, Barsky D, Colvin ME, et al. Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis. J Immunol 2001; 167:29562963.
  • 9
    Takeuchi M, Hamana K, Hiraishi A. Proposal of the genus Sphingomonas sensu stricto and three new genera, Sphingobium, Novosphingobium and Sphingopyxis, on the basis of phylogenetic and chemotaxonomic analyses. Int J Syst Evol Microbiol 2001; 51:14051417.
  • 10
    Shuttleworth KL, Sung J, Kim E, Cerniglia CE. Physiological and genetic comparison of two aromatic hydrocarbon-degrading Sphingomonas strains. Mol Cell 2000; 10:199205.
  • 11
    Shi T, Fredrickson JK, Balkwill DL. Biodegradation of polycyclic aromatic hydrocarbons by Sphingomonas strains isolated from the terrestrial subsurface. J Ind Microbiol Biotechnol 2001; 26:283289.
  • 12
    Fredrickson JK, Balkwill DL, Drake GR, Romine MF, Ringelberg DB, White DC. Aromatic-degrading Sphingomonas isolates from the deep subsurface. Appl Environ Microbiol 1995; 61:19171922.
  • 13
    Fujii K, Kikuchi S, Satomi M, Ushio-Sata N, Morita N. Degradation of 17beta-estradiol by a gram-negative bacterium isolated from activated sludge in a sewage treatment plant in Tokyo, Japan. Appl Environ Microbiol 2002; 68:20572060.
  • 14
    Lemaitre D, Elaichouni A, Hundhausen M, Claeys G, Vanhaesebrouck P, Vaneechoutte M, Verschraegen G. Tracheal colonization with Sphingomonas paucimobilis in mechanically ventilated neonates due to contaminated ventilator temperature probes. J Hosp Infect 1996; 32:199206.
  • 15
    Perola O, Nousiainen T, Suomalainen S, Aukee S, Karkkainen UM, Kauppinen J, Ojanen T, et al. Recurrent Sphingomonas paucimobilis-bacteraemia associated with a multi-bacterial water-borne epidemic among neutropenic patients. J Hosp Infect 2002; 50:196201.
  • 16
    Lee YM, Kaplan MM. Management of primary sclerosing cholangitis. Am J Gastroenterol 2002; 97:528534.
    Direct Link:
  • 17
    Hakala M, Pollanen R, Nieminen P. The ARA 1987 revised criteria select patients with clinical rheumatoid arthritis from a population based cohort of subjects with chronic rheumatic diseases registered for drug reimbursement. J Rheumatol 1993; 20:16741678.
  • 18
    Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993; 18:9981005.
  • 19
    Ludwig J, Dickson ER, McDonald GS. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol 1978; 379:103112.
  • 20
    Miyakawa H, Tanaka A, Kikuchi K, Matsushita M, Kitazawa E, Kawaguchi N, Fujikawa H, et al. Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens. Hepatology 2001; 34:243248.
  • 21
    Migliaccio C, Nishio A, Van de Water J, Ansari AA, Leung PS, Nakanuma Y, Coppel RL, et al. Monoclonal antibodies to mitochondrial E2 components define autoepitopes in primary biliary cirrhosis. J Immunol 1998; 161:51575163.
  • 22
    Sasaki M, Ansari A, Pumford N, van de Water J, Leung PS, Humphries KM, Szweda LI, et al. Comparative immunoreactivity of anti-trifluoroacetyl (TFA) antibody and anti-lipoic acid antibody in primary biliary cirrhosis: searching for a mimic. J Autoimmun 2000; 15:5160.
  • 23
    Hiramatsu K, Harada K, Tsuneyama K, Sasaki M, Fujita S, Hashimoto T, Kaneko S, et al. Amplification and sequence analysis of partial bacterial 16S ribosomal RNA gene in gallbladder bile from patients with primary biliary cirrhosis. J Hepatol 2000; 33:918.
  • 24
    Tanaka A, Prindiville TP, Gish R, Solnick JV, Coppel RL, Keeffe EB, Ansari A, et al. Are infectious agents involved in primary biliary cirrhosis? A PCR approach. J Hepatol 1999; 31:664671.
  • 25
    Parikh-Patel A, Gold E, Mackay IR, Gershwin ME. The geoepidemiology of primary biliary cirrhosis: contrasts and comparisons with the spectrum of autoimmune diseases. Clin Immunol 1999; 91:206218.
  • 26
    Metcalf J, James O. The geoepidemiology of primary biliary cirrhosis. Semin Liver Dis 1997; 17:1322.
  • 27
    Gershwin ME, Ansari AA, Mackay IR, Nakanuma Y, Nishio A, Rowley MJ, Coppel RL. Primary biliary cirrhosis: an orchestrated immune response against epithelial cells. Immunol Rev 2000; 174:210225.
  • 28
    Weber B, Berger A, Doerr HW. Detection of retroviral antibodies in primary biliary cirrhosis. Lancet 1998; 352:149.
  • 29
    Xu L, Shen Z, Guo L, Fodera B, Keogh A, Joplin R, O'Donnell B, et al. Does a betaretrovirus infection trigger primary biliary cirrhosis? Proc Natl Acad Sci U S A 2003; 100:84548459.
  • 30
    Leung PS, Park O, Gershwin ME. Is there a relation between Chlamydia infection and primary biliary cirrhosis? Hepatology 2002; 36:388A.
  • 31
    Butler P, Hamilton-Miller JM, McIntyre N, Burroughs AK. Natural history of bacteriuria in women with primary biliary cirrhosis and the effect of antimicrobial therapy in symptomatic and asymptomatic groups. Gut 1995; 36:931934.
  • 32
    O'Donohue J, Workman MR, Rolando N, Yates M, Philpott-Howard J, Williams R. Urinary tract infections in primary biliary cirrhosis and other chronic liver diseases. Eur J Clin Microbiol Infect Dis 1997; 16:743746.
  • 33
    Reddy KR, Colombel JF, Poulain D, Krawitt EL. Anti-Saccharomyces cerevisiae antibodies in autoimmune liver disease. Am J Gastroenterol 2001; 96:252253.
    Direct Link:
  • 34
    Muratori P, Muratori L, Guidi M, Maccariello S, Pappas G, Ferrari R, Gionchetti P, et al. Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases. Clin Exp Immunol 2003; 132:473476.
  • 35
    Odin JA, Huebert RC, Casciola-Rosen L, LaRusso NF, Rosen A. Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. J Clin Invest 2001; 108:223232.